No Concealer Concealer
Natural health product licensed in Canada
- Licence holder
- NV Perricone LLC
- NPN or DIN-HM
- 80069509
- Status
- Active licence
- Licence date
- 17 May 2016
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Dioxyde de titane | 4.8 Pour cent |
Non-medicinal ingredients
Olivate de sorbitan, Poly(glycéryl-3) poly(diméthylsiloxyéthyl) diméthicone, Triéthoxysilyléthyl polydiméthylsiloxyéthyl hexyle diméthicone, Polymère croisé de diméthicone/vinyl diméthicone, Tribéhénin, Palmitoyl tripeptide-1, Triéthoxycaprylylsilane, PEG/PPG-18/18 diméthicone, Ethylhexylglycérine, Olivate de cétéaryle, Polymère croisé de diméthicone/PEG-10/15, Glucosyl hespéridine, Hydroxypropyle Cyclodextrine, Benzoate d'alkyle en C12 à 15, Mica, Palmitate d'éthylhexyle, Cyclopentasiloxane, Hydroxyde d'aluminium, Ascorbate de tétrahexyldécyle, Caprylyl glycol, Eau, Silice, Propylène glycol, Cyclotetrasiloxane, Glycérine, Palmitoyl tripeptide-38, Cétyl PEG/PPG-10/1 Diméthicone, Hexapeptide-12 de palmitoyle, Acide stéarique, Diméthicone, Céramide 2, Acide hyaluronique, Tétrapeptide-7 de palmitoyl, Copolymère de PPG-12/SMDI, Chrysine, Laurate d'hexyle, Phénoxyéthanol, Chlorophosphate de linoléamidopropyl PG-dimonium, N-Hydroxysuccinimide, Nylon-12, Diméthyl MEA, Stérol de colza de PEG-10, Oxydes de fer, Hexylène Glycol, Acétate de dl-alpha tocophéryle, Butylène glycol, PCA de sodium, Stéareth-20, C.I. n° 77891, Isostéarate de poly(glycéryle-4)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | Not specified | Not specified |
Uses authorised in Canada
SPF 35
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Discontinue use if skin irritation develops or increases. If irritation persists, consult a health care practitioner. Avoid contact with eyes.
Source
Official Health Canada record, licence 80069509
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.